Skip to Content

NEW

A vastly improved search engine helps you find the latest on companies, business leaders, and news more easily.

SIGN IN

Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Health
The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
By
Sy Mukherjee
and
IDEA Pharma
April 20, 2022
Newsletters
The science behind a fond farewell
By
Sy Mukherjee
September 23, 2021
Health
Health insurers justify passing COVID treatment costs on to patients despite massive profits
By
Sy Mukherjee
September 23, 2021
Health
What comes next for COVID booster shots after the FDA panel hedges on Pfizer
By
Sy Mukherjee
September 17, 2021
Newsletters
The failed bid to topple Gavin Newsom and the politics of public health
By
Sy Mukherjee
September 16, 2021
Health
3 things you should know about the timeline for kids’ COVID vaccines
By
Sy Mukherjee
September 16, 2021
Newsletters
20 years after 9/11, first responders are still sick, dying, and underpaid
By
Sy Mukherjee
September 9, 2021
Health
Parkinson’s disease has no approved treatment. Scientists want to use lab grown mini-brains to change that
By
Sy Mukherjee
September 8, 2021
Newsletters
There have been 154 retracted COVID studies. The damage may already be done
By
Sy Mukherjee
September 2, 2021
Health
The psychology behind why people will take horse paste, but not COVID vaccines
By
Sy Mukherjee
September 2, 2021
Health
1 in 3 Americans had COVID in 2020, according to new research
By
Sy Mukherjee
August 27, 2021
Newsletters
Google Health is being dismantled, but Big Tech’s quixotic health ambitions persist
By
Sy Mukherjee
August 26, 2021
Health
Booster shots for Johnson & Johnson COVID vaccines could be coming soon
By
Sy Mukherjee
August 25, 2021
Health
Why it’s taking so long to get COVID vaccines for kids under 12
By
Sy Mukherjee
August 25, 2021
Health
What Pfizer’s FDA approval means for Americans and businesses
By
Sy Mukherjee
August 24, 2021

1 - 15 of 1,924 results

1 - 15 of 1,924 results